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Abstract 
Protein quality control (PQC) is a critical process wherein misfolded or damaged proteins are 
cleared from the cell to maintain protein homeostasis. In eukaryotic cells, the removal of misfolded 
proteins is primarily accomplished by the ubiquitin-proteasome system (UPS). In the UPS, 
ubiquitin-conjugating enzymes and ubiquitin ligases append poly-ubiquitin chains onto misfolded 
protein substrates signaling for their degradation. The kinetics of protein ubiquitylation are 
paramount since a balance must be achieved between the rapid removal of misfolded proteins 
versus providing sufficient time for protein chaperones to attempt refolding. To uncover the 
molecular basis for how PQC substrate ubiquitylation rates are controlled, the reaction catalyzed 
by nuclear ubiquitin ligase San1 was reconstituted in vitro. Our results demonstrate that San1 can 
function with 2 ubiquitin-conjugating enzymes, Cdc34 and Ubc1. While Cdc34 and Ubc1 are both 
sufficient for promoting San1 activity, San1 functions preferentially with Ubc1, including when 
both Ubc1 and Cdc34 are present. Notably, a homogeneous peptide that mimics a misfolded PQC 
substrate was developed and enabled quantification of the kinetics of San1-catalyzed 
ubiquitylation reactions. We discuss how these results may have broad implications for the 
regulation of PQC-mediated protein degradation. 
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Introduction 
In order for cells to maintain proteostasis, a delicate balance must exist between protein 
translation and degradation. The UPS is a network of proteins and enzymes responsible for 70-80 
percent of intracellular protein degradation in eukaryotic cells (Kleiger & Mayor, 2014). The 
signal for protein degradation is the assembly of a poly-ubiquitin chain onto protein substrate.  
 Ubiquitylation occurs through the sequential action of three enzymes: E1 (ubiquitin-
activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase) (Deshaies & 
Joazeiro, 2009; Komander & Rape, 2012; Schulman & Harper, 2009; Ye & Rape, 2009). E1 
activates ubiquitin, a highly conserved, 76 amino acid protein, forming a thioester bond between 
the C-terminal carboxy group on ubiquitin and a cysteine residue located within the E1 active 
site. Next, ubiquitin is transferred from E1 to E2. The E2~ubiquitin (~ is used to denote a 
thioester bond) is then recruited by an E3, which brings the E2~ubiquitin and protein substrate 
into proximity. E3s may also participate in ubiquitylation by stimulating the ubiquitin transfer 
activity of E2s (Branigan, Plechanovova, Jaffray, Naismith, & Hay, 2015; Das et al., 2013; Dou, 
Buetow, Sibbet, Cameron, & Huang, 2012; Plechanovova, Jaffray, Tatham, Naismith, & Hay, 
2012; Pruneda et al., 2012; Scott et al., 2014). In most cases, ubiquitin is transferred from 
E2~ubiquitin to the protein substrate, forming an isopeptide bond between ubiquitin’s C-
terminus and a lysine residue on the substrate. The dissociation of E2s from E3 and the binding 
of fresh E2~ubiquitin complexes enables the formation of a poly-ubiquitin chain on the substrate. 
Typically, a chain of at least 4 ubiquitins is required for a substrate to be recognized by the 26S 
proteasome for degradation (Piotrowski et al., 1997; Thrower, Hoffman, Rechsteiner, & Pickart, 
2000); however, the modification of several lysine residues with a single ubiquitin on some 
substrates may also be sufficient (Lu, Lee, King, Finley, & Kirschner, 2015; Shabek et al., 2012). 
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PQC is a critical pathway within the UPS that is responsible for removing misfolded proteins 
from the cell (Chen, Retzlaff, Roos, & Frydman, 2011). PQC systems are prevalent throughout 
the cell and can be found at important multi-subunit complexes such as the ribosome (Bengtson 
& Joazeiro, 2010; Brandman & Hegde, 2016; Verma, Oania, Kolawa, & Deshaies, 2013; Wang, 
Durfee, & Huibregtse, 2013), and in the cytoplasm (Eisele & Wolf, 2008; Fang et al., 2014; 
Fang, Ng, Measday, & Mayor, 2011; Heck, Cheung, & Hampton, 2010; Murata, Minami, 
Minami, Chiba, & Tanaka, 2001) and organelles such as the endoplasmic reticulum (Buchberger, 
Bukau, & Sommer, 2010; Christianson & Ye, 2014), mitochondria (Baker, Tatsuta, & Langer, 
2011), and nucleus (Gardner, Nelson, & Gottschling, 2005). Not surprisingly, the breakdown of 
normal PQC function may lead to several human diseases. For instance, lesions formed in 
patients with neurodegenerative diseases including Huntington’s, Alzheimer’s and Parkinson’s 
contain a conglomeration of aggregated proteins including UPS enzymes as well as numerous 
poly-ubiquitylated proteins that have evaded degradation (Aguzzi & O'Connor, 2010; Tramutola, 
Di Domenico, Barone, Perluigi, & Butterfield, 2016). Furthermore, mutations in several key 
enzymes that promote mitophagy through ubiquitylation-specific mechanisms have been found 
in patients with Parkinson’s disease (Heo, Ordureau, Paulo, Rinehart, & Harper, 2015; Lee, 
Nagano, Taylor, Lim, & Yao, 2010; Sarraf et al., 2013). Finally, inclusions associated with 
Huntington’s disease are localized to the nucleus, suggesting a breakdown of nuclear PQC 
processes in those patients (Amm, Sommer, & Wolf, 2014; Woulfe, 2008). 
Nuclear PQC in the budding yeast Saccharomyces cerevisiae is controlled by the San1 
ubiquitin ligase (Dasgupta, Ramsey, Smith, & Auble, 2004; Gardner et al., 2005). San1 contains 
highly disordered regions that identify misfolded substrates by binding to exposed hydrophobic 
stretches on the substrate (Fredrickson, Clowes Candadai, Tam, & Gardner, 2013; Fredrickson, 
3 
 
Gallagher, Clowes Candadai, & Gardner, 2013; Fredrickson, Rosenbaum, Locke, Milac, & 
Gardner, 2011; Gallagher, Clowes Candadai, & Gardner, 2014; Rosenbaum et al., 2011; 
Rosenbaum & Gardner, 2011). Genetic results have suggested that San1 recruits the E2s Cdc34 
and Ubc1 to form poly-ubiquitin chains on misfolded proteins (Gardner et al., 2005). 
Interestingly, previous work has shown that many E3s ubiquitylate their protein substrates with 
at least 2 distinct members of the E2 family (Christensen, Brzovic, & Klevit, 2007; J. H. Kim et 
al., 2015; Rodrigo-Brenni & Morgan, 2007; Wickliffe, Lorenz, Wemmer, Kuriyan, & Rape, 
2011; Wickliffe, Williamson, Meyer, Kelly, & Rape, 2011; Williamson et al., 2009; Wu, 
Kovacev, & Pan, 2010). In these examples, an E2 initiates poly-ubiquitin chain formation by 
transferring the first ubiquitin to the E3-bound substrate, whereas a different E2 is responsible 
for chain elongation. Thus, it is possible that San1 may also function synergistically with both 
Cdc34 and Ubc1 during nuclear PQC substrate ubiquitylation. However, it is also possible that 
Cdc34 and Ubc1 may function independently with San1.  
To distinguish between these 2 hypotheses, an in vitro PQC ubiquitylation system was 
reconstituted containing E1, ubiquitin, San1, a PQC substrate, and either Cdc34 or Ubc1 alone or 
in combination. Our results show robust E3-dependent ubiquitylation of substrate in the presence 
of either Ubc1 or Cdc34; however, Ubc1 consistently shows greater activity with San1 than does 
Cdc34. Furthermore, to the best of our knowledge, we have developed the first homogeneous 
peptide substrate for PQC, enabling the use of quantitative enzyme kinetics to characterize the 
San1 ubiquitylation reaction. The results from these experiments suggest that San1 prefers to 
function with Ubc1, even in the presence of Cdc34. 
4 
 
Results 
To uncover whether Cdc34 and Ubc1 may function synergistically with San1, an in vitro 
ubiquitylation reaction was reconstituted that detected San1 auto-ubiquitylation. Full-length San1 
protein was expressed and purified from bacterial cells (Fig. 1). Since a single lysine San1 would 
allow for the specific monitoring of poly-ubiquitin chain formation without the potentially 
confounding effects of multi-mono-ubiquitylation, all naturally occurring San1 lysine residues 
were mutated to arginine, and a single lysine was introduced at Asn 13 since previous 
experiments in yeast demonstrated that N13K San1 was auto-ubiquitylated. 
 
 
 
 
 
  
  
 
 
 
 
 
Figure 1. The final purities of WT Cdc34, Δ190 Cdc34 lacking the acidic tail, WT Ubc1, and full-length San1. 
Approximately 1 ug of protein was loaded onto a SDS-PAGE gel that, following electrophoresis, was stained with 
coomassie blue. The final purity for KR (No Lys) San1 is shown and is similar to the purities of all San1 constructs. 
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Radio-labeled N13K San1 was rapidly ubiquitylated in the presence of E1, ubiquitin, and 
WT yeast Cdc34 (Fig. 2A). The formation of extensive poly-ubiquitin chains on N13K San1 was 
evident as early as 15 seconds. The fraction of San1 proteins that had been modified by one or 
more ubiquitins was linear during the time course, enabling the determination of the rate of 
ubiquitylation (some 14 percent of San1 was modified per minute; Fig. 2B). Furthermore, the 
location of the single lysine at the N-terminus of San1 was not important for promoting San1 
auto-ubiquitylation, since a San1 protein containing a single lysine at the C-terminus, N444K 
San1, was auto-ubiquitylated with similar kinetics as N13K San1 (Fig. 2C, D). 
Most E3s contain a conserved RING domain that recruits E2~ubiquitin (Deshaies & 
Joazeiro, 2009). N13K San1 that contained an additional mutation known to disrupt RING-E2 
interactions (Pruneda et al., 2012) (N13K/R280A San1) was produced and was incapable of 
auto-ubiquitylation (Fig. 2E), demonstrating that San1 activity was dependent on the interaction 
between Cdc34~ubiquitin and the San1 RING domain. 
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 San1 auto-ubiquitylation was next assayed in the presence of WT Ubc1. Poly-ubiquitin 
chain formation on N13K San1 was substantially more rapid than in the presence of Cdc34, and 
the poly-ubiquitin chains were substantially longer as well (Fig. 3A). Although the amount of 
N13K San1 auto-ubiquitylated product quickly diverged from linearity during the time-course 
(Fig. 3B), the data fit well to a single phase exponential function, allowing for the estimation of 
the initial rate of San1 modification (see materials and methods) and comparison to the rate of 
San1 auto-ubiquitylation with Cdc34. Impressively, the rate of San1 ubiquitylation was nearly 8 
times greater in the presence of Ubc1 than with Cdc34. San1 auto-ubiquitylation was greatly 
Figure 2. Single lysine San1 is rapidly auto-ubiquitylated in the presence of WT Cdc34. (A) Time-course showing 
auto-ubiquitylation of radiolabeled N13K San1 in the presence of WT Cdc34, E1, and ubiquitin. Product is defined 
as any San1 protein that has been modified by one or more ubiquitins. (B) Quantitation of the fraction of N13K San1 
that was converted to ubiquitylated product. Notice that the fraction of San1 product was linear with respect with 
time. Error bars represent the standard errors of measurements from duplicate data points. (C) Same as in (A), but 
with N444K San1. (D) Same as in (B), but with N444K San1. (E) Same as in (A), but with N13K/R280A San1. 
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reduced in the presence of N13K/R280A San1, although some product formation was evident 
towards the end of the time course (Fig. 3C), hinting that Ubc1 may have greater affinity for 
San1 and/or greater catalytic activity in the presence of San1 as compared with Cdc34. Finally, 
similar to reactions containing Cdc34, N444K San1 was also rapidly auto-ubiquitylated in the 
presence of Ubc1 (Fig. 3D, E).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Single lysine San1 is auto-ubiquitylated more rapidly in the presence of WT Ubc1 than with Cdc34. (A) 
Time-course showing auto-ubiquitylation of radiolabeled N13K San1 in the presence of WT Ubc1, E1, and ubiquitin. 
(B) Quantitation of the fraction of N13K San1 that had been modified by one or more ubiquitins. Notice that product 
formation strays from linearity early in the time-course due to rapid conversion of San1 into product. Error bars 
represent the standard errors of measurements from duplicate data points. (C) Same as in (A), but with N13K/R280A 
San1. (D) Same as in (A), but with N444K San1. (E) Same as in (B), but with N444K San1. 
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E2 activity is often stimulated in the presence of E3 through highly specific interactions 
at the E2~ubiquitin–E3 interface (Branigan et al., 2015; Das et al., 2013; Dou et al., 2012; 
Plechanovova et al., 2012; Pruneda et al., 2012; Scott et al., 2014). However, E2 activation only 
occurs for selective E2-E3 pairs, and E2 stimulation by an E3 in vitro is therefore evidence of a 
functional interaction. To explore this possibility for San1 and either Cdc34 or Ubc1, we used a 
previously described assay (Kleiger, Hao, Mohl, & Deshaies, 2009) that measures E2 activity in 
either the absence or presence of San1. Briefly, E2 is first thioesterified to 32P-labeled ubiquitin 
with E1, and the reaction is then initiated by adding unlabeled ubiquitin. Chain formation 
between unlabeled and labeled ubiquitin results in the formation of a di-ubiquitin product. WT 
Cdc34 activity was first measured in the absence of San1 (Fig. 4A, G and Table 1). The same 
reaction was then repeated in the presence of KR San1 (that contains no lysine residues and 
doesn’t get auto-ubiquitylated), resulting in a 2-fold increase in Cdc34 activity (Fig. 4B, G and 
Table 1). This modest increase in Cdc34 activity was dependent on Cdc34 binding to the San1 
RING domain, since N13K/R280A San1 did not activate Cdc34 (Fig. 4C, G and Table 1).  
While KR San1 increased Cdc34 activity by 2-fold, this result was unimpressive, since 
Cdc34 activity was greatly stimulated in the presence of the human SCF subunits Cul1–Rbx1 
(Fig. 4D, H and Table 1). Indeed, the stimulation of WT Cdc34 activity by Cul1–Rbx1 was 
comparable to the stimulation of human Cdc34 (Ube2R1/2) activity by Cul1–Rbx1 (Fig. 4E, F, 
H and Table 1). Thus, San1 activation of yeast Cdc34 was modest when compared to Cdc34 
activation by Cul1–Rbx1. 
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The activity of Ubc1 was next measured using the di-ubiquitin synthesis assay in both the 
presence and absence of KR San1. Interestingly, E3-independent Ubc1 activity was 10 times 
slower in comparison with yeast Cdc34 (Fig. 5A, E and Table 1). However, the presence of KR 
San1 stimulated Ubc1 activity by approximately 38-fold and in a RING-dependent manner (Fig. 
5B, C, E and Table 1). Furthermore, the stimulation of Ubc1 by San1 was specific, since the 
Figure 4. WT Cdc34 activity is only weakly stimulated in the presence of San1. (A) Di-ubiquitin synthesis assay for 
WT Cdc34 (yCdc34) showing the time dependent formation of di-ubiquitin product. (B) Same as in (A) except KR 
San1 was added to the reaction mixture prior to initiation of the reaction by the addition of acceptor ubiquitin. (C), 
Same as in (B) except with N13K/R280A San1. (D) Same as in (A) except the human SCF Cul1–Rbx1 sub-complex 
was added to the reaction prior to acceptor ubiquitin. (E) Same as in (A) except with human WT Cdc34 (hCdc34). 
(F) Same as in (E) except with the addition of Cul1–Rbx1. (G) Quantitation of di-ubiquitin formation for reactions 
in (A-C). Notice that the presence of KR San1 resulted in only modest stimulation of yCdc34 activity. (H) 
Quantitation of di-ubiquitin formation for reactions in (D-F), showing that both yeast and human WT Cdc34 activities 
were significantly stimulated in the presence of Cul1–Rbx1. Due to the rapid formation of di-ubiquitin for both 
hCdc34 and yCdc34 in the presence of Cul1–Rbx1 (and the subsequent deviation of product formation with linearity), 
notice that only two and three data points, respectively, were used to determine the rates of product formation. Error 
bars represent the standard errors of measurements from duplicate data points. 
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presence of Cul1–Rbx1 had no effect on Ubc1 activity (Fig. 5D, E and Table 1). Taken together, 
these results demonstrate than San1 is capable of activating both yeast Cdc34 and Ubc1, 
although Ubc1 stimulation by San1 is far more impressive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Ubc1 activity is strongly stimulated in the presence of San1. (A) Di-ubiquitin synthesis assay for WT Ubc1 
showing the time-dependent formation of di-ubiquitin product. (B) Same as in (A) except KR San1 was added to the 
reaction mixture prior to the addition of acceptor ubiquitin. (C) Same as in (B) except with N13K/R280A San1. (D) 
Same as in (C) except with Cul1–Rbx1. Notice that the presence of KR San1 resulted in the stimulation of Ubc1 
activity; however, the addition of Cul1–Rbx1 had no effect on Ubc1 activity. (E) Quantification of di-ubiquitin 
formation for reactions in (A-D). Error bars represent the standard errors of measurements from duplicate data points. 
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Table 1. Rates of di-ubiquitin formation for either WT Cdc34 or Ubc1 in the presence or absence of E3s. 
 
E2 E3 
Rate of Ub Transfer 
(pMoles min-1) Fold Change 
WT yCdc34 - 5.6 ± 0.1 - 
WT yCdc34 N13K/R280A San1 4.8 ± 0.2 1 
WT yCdc34 KR San1 11.0 ± 1.1 2 
WT yCdc34 Cul1–Rbx1 136.6 ± 6.5 24 
WT hCdc34 - 9.7 ± 0.7 - 
WT hCdc34 Cul1–Rbx1 283.6 ± 6.7 29 
WT Ubc1 - 0.5 ± 0.04 - 
WT Ubc1 N13K/R280A San1 1.5 ± 0.05 3 
WT Ubc1 KR San1 18.9 ± 1.9 38 
WT Ubc1 Cul1–Rbx1 0.7 ± 0.03 1 
 
 
A Novel in vitro Reconstituted Ubiquitylation Reaction with San1-bound Substrate 
Demonstrates that San1 Functions Preferentially with Ubc1 
The results presented thus far suggest that while both WT Cdc34 and Ubc1 can function 
in vitro with San1, Ubc1 has greater activity and is also stimulated to a far greater extent in the 
presence of San1. However, the mechanism of San1 auto-ubiquitylation may differ substantially 
in comparison with a reaction involving a San1-bound PQC substrate. To address this, a bona 
fide PQC substrate that would enable quantitative enzyme kinetics was developed.  
 It had previously been shown that introducing a small, hydrophobic patch in the San1 
amino acid sequence resulted in increased turnover of San1 protein in yeast (Fredrickson, 
Clowes Candadai, et al., 2013). In those experiments, the RING domain in San1 had been 
mutated to eliminate auto-ubiquitylation. Finally, the mutant San1 protein was rapidly degraded 
in cells containing endogenous WT San1, but not in cells where the San1 gene had been deleted. 
Thus, the hydrophobic San1 protein mimics a PQC substrate that is recognized by endogenous 
12 
 
San1. We reasoned that a synthetic peptide containing the hydrophobic patch and a single nearby 
lysine residue at the C-terminus may function as a minimal San1 substrate in vitro. To help 
increase the peptide’s solubility in aqueous buffer, 13 residues immediately N-terminal to the 
hydrophobic patch in San1 were also included since many of the residues are hydrophilic.  
 San1 peptide ubiquitylation reactions were first assembled in the presence of KR San1 
and WT Cdc34. Poly-ubiquitin chains were rapidly assembled onto the San1 peptide but not in 
reactions lacking San1 (Fig. 6A). Furthermore, the peptide was not ubiquitylated in the presence 
of N13K/R280A San1, indicating that an intact RING domain was required to recruit Cdc34 
(Fig. 6A). Since it is well-known that Cdc34 generates Lys 48-specific poly-ubiquitin chains on 
SCF-bound substrates (Petroski & Deshaies, 2005), the chain linkage specificity of the chains on 
the San1 peptide was also assessed. Indeed, San1 peptide ubiquitylation was similar in reactions 
comparing either WT ubiquitin or a ubiquitin mutant in which all lysine residues except Lys 48 
had been mutated to arginine (Fig. 6B). San1 peptide ubiquitylation reactions were next 
assembled in the presence of KR San1 and WT Ubc1. Similar to Cdc34, poly-ubiquitin chains 
were rapidly assembled onto the San1 peptide in the presence of Ubc1 in a Lys 48-dependent 
manner (Fig. 6B). 
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One caveat regarding in vitro reconstituted ubiquitylation reactions is that non-
physiological E2-E3 pairs are often active in the presence of very high concentrations of E2, 
whereas physiological E2-E3 pairs will typically interact with high affinity. The in vitro 
ubiquitylation system with San1 peptide enabled estimation of the Km of either Cdc34 or Ubc1 
for San1. Note that the Km of an E2 for E3 has a long-standing history as a proxy of E2-E3 
affinity, including in studies involving Cdc34 and ubiquitin ligase SCF, Ubc1 and the Anaphase 
Promoting Complex (APC) ubiquitin ligase, as well as numerous other E2-E3 pairs (Kleiger, 
Figure 6. San1 peptide is rapidly ubiquitylated in the presence of KR San1. (A) Multi-turnover ubiquitylation 
reactions were carried out in the presence of WT Cdc34 and either KR San1 or N13K/R280A San1. Notice that San1 
peptide becomes ubiquitylated only in the presence of KR San1 indicating that the San1 RING domain and 
subsequent recruitment of Cdc34~ubiquitin are required for substrate ubiquitylation. PO (peptide only) indicates a 
reaction containing San1 peptide where all additional reaction components were excluded. (B) Multi-turnover 
ubiquitylation reactions in either the presence of WT Cdc34 or WT Ubc1 and either WT ubiquitin or a Lys 48 only 
ubiquitin mutant (K48O). Notice that product formation is similar in reactions containing WT or K48O ubiquitin, 
indicating that both WT Cdc34 and Ubc1 likely generate poly-ubiquitin chains on San1 peptide that are Lys 48-
specific. 
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Hao, et al., 2009; Kleiger, Saha, Lewis, Kuhlman, & Deshaies, 2009; Rodrigo-Brenni & Morgan, 
2007).  
 The Km of either Cdc34 or Ubc1 for San1 was estimated by measuring the rate of San1 
peptide ubiquitylation in the presence of varying concentrations of E2. The Km of WT yeast 
Cdc34 was 1.7 μM for San1 (Fig. 7A). This was unexpected considering that the Km of WT 
Cdc34 for yeast SCF is approximately 0.2 μM, demonstrating that Cdc34 has substantially 
weaker affinity for San1 in comparison to SCF. On the other hand, the Km of WT Ubc1 was 
0.09 μM for San1 (Fig. 7B), nearly 19-fold lower than in comparison with Cdc34. Interestingly, 
this value is also substantially lower than the Km of Ubc1 for the APC (which is well-known to 
function with Ubc1 in vivo) (Rodrigo-Brenni & Morgan, 2007), indicating that Ubc1 has greater 
affinity for San1 than for the APC. 
Cdc34 contains an atypical C-terminal extension with several highly conserved acidic 
residues. This domain (termed the acidic tail) has been shown to be a critical determinant in the 
high affinity binding of Cdc34 to SCF (Kleiger, Saha, et al., 2009). To ascertain whether the 
Cdc34 acidic tail has a role in promoting Cdc34 binding to San1, a Cdc34 tail deletion mutant, 
Δ190 Cdc34, was purified and its Km for San1 was estimated. The Km of Δ190 Cdc34 for San1 
was 2.2 μM (Fig. 7C), comparable to the Km of WT Cdc34 for San1. Thus, the Cdc34 acidic tail 
does not affect the binding of yeast Cdc34 to San1. 
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Figure 7. Ubc1 has greater affinity for San1 than Cdc34. (A) San1 peptide ubiquitylation reactions containing KR 
San1 and titrations of WT Cdc34 protein. Each lane represents a single ubiquitylation reaction that was quenched 
with 2X SDS-PAGE loading buffer after 10 minutes. Error bars represent the standard errors of measurements from 
duplicate data points. (B) Same as in (A) except with WT Ubc1. Reactions were quenched with SDS-PAGE loading 
buffer after 6 minutes. (C) Same as in (A) except with Δ190 Cdc34. Notice that deletion of the Cdc34 acidic tail does 
not affect the affinity of Cdc34 for San1. 
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To determine if Cdc34 and Ubc1 function synergistically, San1 peptide ubiquitylation 
was initiated in the presence of either Cdc34 or Ubc1 alone or together (Fig. 8A), and the 
fraction of San1 peptide products containing one or more ubiquitins was quantified (Fig. 8B). 
While reactions containing WT Cdc34 resulted in poly-ubiquitin chain formation on the San1 
peptide as early as 1.5 minutes into the time-course, product formation with Ubc1 was even more 
robust and apparent as early as 45 seconds. Additionally, the formation of long poly-ubiquitin 
chains onto substrate (visualized as smears towards the top of the gel) was favored in reactions 
containing Ubc1 alone in comparison with those containing Cdc34 alone.  
 The presence of equal concentrations of both Ubc1 and Cdc34 in the presence of 
KR San1 and peptide resulted in similar amounts of substrate conversion to product in 
comparison to the reaction containing Ubc1 only (Fig. 8B). Interestingly, the high molecular-
weight poly-ubiquitin chains on substrate were mildly diminished in contrast to the reaction 
containing only Ubc1 (Fig. 8A). These results allow for 2 major conclusions: (1) ubiquitylation 
of San1 peptide is more robust in the presence of Ubc1 than with WT Cdc34; and (2) the 
combination of Ubc1 and Cdc34 in a ubiquitylation reaction does not further enhance product 
formation when compared to the reaction with Ubc1 alone. Thus, Ubc1 and WT Cdc34 do not 
function synergistically with San1 in vitro, and the presence of Cdc34 may even mildly inhibit 
the formation of long poly-ubiquitin chains by Ubc1. 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. San1 functions preferentially with Ubc1 over WT Cdc34. (A) San1 peptide multi-turnover ubiquitylation 
reactions were carried out in the presence of KR San1 and either WT Ubc1 alone, WT Cdc34 alone, or Ubc1 and WT 
Cdc34 in combination. Notice that reactions with Ubc1 show intense high molecular-weight smears corresponding 
to long poly-ubiquitin chains on substrate in comparison with the reaction containing WT Cdc34 alone. (B) 
Quantification of the conversion of San1 peptide substrate into products containing one or more ubiquitins. Notice 
that substrate is converted to product more rapidly in the presence of Ubc1 than with WT Cdc34, and the reaction 
with both Ubc1 and WT Cdc34 does not further enhance product formation in comparison with Ubc1 alone. Error 
bars represent the standard errors of measurement derived from duplicate data points. 
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Discussion 
Using quantitative kinetics and an in vitro reconstituted ubiquitylation assay, we 
demonstrate that the San1 ubiquitin ligase preferentially functions with Ubc1 over Cdc34. First, 
the affinity of Ubc1 for San1 is much higher in comparison with WT Cdc34. Secondly, Ubc1 
activity is greatly stimulated in the presence of San1, whereas Cdc34 activity is only weakly 
stimulated by San1. Lastly, Ubc1 both initiates poly-ubiquitin chains and extends them more 
rapidly on San1-bound substrate than Cdc34.  
 The greater activity of Ubc1 with San1 in comparison with Cdc34 is surprising given the 
genetic evidence. For instance, the stability of Sir4-9 protein, a model PQC substrate, was 
substantially greater in a cdc34-2 temperature-sensitive yeast strain compared with a ubc1Δ 
strain (Gardner et al., 2005). The discrepancy between the genetic and biochemical results 
presented here may be caused, at least in part, by the cell cycle arrest phenotype induced by the 
cdc34-2 allele. On the other hand, conditions in the nucleus, such as E2 protein levels as well as 
regulation, may affect whether San1 functions preferentially with Cdc34 or Ubc1 in living cells 
(see below). Regardless, this example highlights how in vitro approaches for uncovering 
mechanistic processes of ubiquitylation can be complementary to in vivo ones.    
 The ubiquitylation of San1-bound substrate by Cdc34 is nevertheless comparable with 
Ubc1 (Fig. 8 and Table 1), and it remains possible that San1 may function with Cdc34 in the cell 
if Ubc1 is somehow unavailable. As a case in point, notice that the rate of ubiquitin transfer to 
free ubiquitin for Cdc34 is within 2-fold of Ubc1 in the presence of San1 (Table 1). This occurs 
because while Ubc1 activity in the absence of San1 is far slower than in comparison with Cdc34, 
San1 has a massive impact on Ubc1 activity and only a very modest one with Cdc34 (Table 1). 
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Thus, San1 has evolved to work with these two unique E2s such that their activity levels are 
comparable in the presence of San1. To further elaborate on this point, we next compare and 
contrast Cdc34 activity with ubiquitin ligases SCF and San1 since the detailed mechanism of 
Cdc34 binding to SCF is known. 
E2-E3 Interactions During the Ubiquitylation of PQC Substrates: Why High Affinity 
Binding is Not Always Warranted 
It was noted earlier that the Km of WT Cdc34 for San1 was approximately 10-fold higher 
in comparison with the Km of WT Cdc34 for the ubiquitin ligase SCF (Kleiger, Hao, et al., 
2009). Furthermore, the binding of Cdc34 to San1 is not dependent on the acidic tail domain 
which is essential for Cdc34 function with SCF (Kleiger, Hao, et al., 2009). How can these 
differences be reconciled? 
 To address this question, it is relevant to examine how the acidic tail promotes Cdc34 
binding to SCF. Specifically, the acidic tail drives extremely fast association between 
Cdc34~ubiquitin and SCF by promoting electrostatic interactions between the acidic tail residues 
and a basic canyon located near the RING domain on SCF (Kleiger, Saha, et al., 2009). Thus, 
fast association also enables a rapid rate of Cdc34 dissociation from SCF without compromising 
high affinity binding. Rapid dynamics between Cdc34 and SCF promotes processive ubiquitin 
transfer (Pierce, Kleiger, Shan, & Deshaies, 2009), increasing the probability that a substrate-E3 
encounter will result in substrate ubiquitylation and degradation.  
 The rationale for the efficient ubiquitylation of SCF substrates, which include Cdk 
inhibitors and transcription factors, is that the prompt degradation of these substrates is required 
for proper signal transduction in the cell. Conversely, the efficient degradation of PQC substrates 
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is likely not beneficial to the cell, and may even be harmful. For instance, some proteins may 
only transiently unfold, and protein chaperones may provide these misfolded proteins with 
opportunities to regain their native states (Hipp, Park, & Hartl, 2014; Y. E. Kim, Hipp, Bracher, 
Hayer-Hartl, & Hartl, 2013). Thus, the interaction of Cdc34 with San1 in an acidic-tail 
independent fashion likely serves to decrease the efficiency of poly-ubiquitin chain formation on 
San1-bound substrates.  
 Nevertheless, in order for Cdc34 and San1 to function together, they must somehow form 
a complex without involvement of the Cdc34 acidic tail. Interestingly, the Km of Δ190 Cdc34 for 
San1 is 2.2 μM, whereas the Km of Δ190 Cdc34 for SCF has previously been estimated to be 16 
μM (Kleiger, Hao, et al., 2009). Thus, San1 circumvents the necessity of the acid tail by having 
evolved the ability to bind with higher affinity to Cdc34’s catalytic domain. Interestingly, the 
nuclear concentration of Cdc34 in yeast has been estimated to be approximately 10 μM (Kleiger, 
Hao, et al., 2009), high enough to approach saturation of San1 with Cdc34 given the value of Km 
(1.7 μM for WT Cdc34). Thus, Cdc34~ubiquitin–San1 complexes can still form in the cell; 
however, the dynamics of Cdc34 association and dissociation will likely be far slower without 
participation of the acidic tail, ultimately delaying the subsequent ubiquitylation and degradation 
of misfolded substrates. 
How Multiple E2s Collaborate to Increase the Chances that E3-Substrate Encounters 
Result in Ubiquitylation: The Hand-Off Model 
Further evidence that PQC substrate ubiquitylation evolved to be less efficient compared 
to E3s such as SCF comes from the observation that many E3s including SCF require at least 2 
E2s to function in cells (Christensen et al., 2007; J. H. Kim et al., 2015; Rodrigo-Brenni & 
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Morgan, 2007; Wickliffe, Lorenz, et al., 2011; Wickliffe, Williamson, et al., 2011; Williamson et 
al., 2009; Wu et al., 2010). In what has been termed the hand-off model, an E2~ubiquitin 
transfers the first ubiquitin to E3-bound substrate, and chain elongation is accomplished by a 
different E2 family member. For instance, E2s such as Ubc4 and Ubc5 in yeast (Ube2D1-4 in 
humans) are very good at transferring a single ubiquitin to a lysine residue on an unmodified 
protein substrate, but they are not good at building poly-ubiquitin chains. Conversely, other E2s, 
such as Cdc34 and Ubc1, are inefficient at transferring the first ubiquitin to substrate but are very 
good at building poly-ubiquitin chains. When E3s such as SCF recruit members from both 
groups of E2s, the rate of conversion of substrate to poly-ubiquitylated product is increased. By 
relying only on either Cdc34 or Ubc1 to initiate as well as to extend chains, San1 encounters 
with misfolded substrates likely results in a lower frequency of substrate poly-ubiquitylation, 
affording them precious time to recover their native folds.  
 To demonstrate this in vitro, single-turnover ubiquitylation reactions were assembled 
with either yeast Cdc34 or Ubc1 and San1 or with UbcH5c and human Cdc34 in combination 
with SCF (Fig. 9). Notice that while approximately 15 percent of San1 peptide substrate is 
modified with one or more ubiquitins after 60 seconds, nearly all of the SCF substrate has been 
converted to ubiquitylated product within 10 seconds. Furthermore, chain elongation on the SCF 
substrate is far more extensive than on the San1 peptide, hinting that the SCF-catalyzed reaction 
is also more processive than the San1-catalyzed one. 
Why Does San1 Need 2 E2s that Function Independent of Each Other?  
If San1 doesn’t function synergistically with Cdc34 and Ubc1 through a hand-off based 
mechanism, why would San1 function with Cdc34 at all since it prefers Ubc1? First, notice that 
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Cdc34 still assembles poly-ubiquitin chains containing 4 or more ubiquitins on a significant 
fraction of San1 peptides even in the absence of Ubc1 (Fig. 8). Furthermore, it is possible that 
Ubc1 activity may decrease under certain physiological conditions such as stress, or during 
certain phases of the cell cycle. Since the constant presence of misfolded proteins in the cell 
requires that PQC processes remain vigilant, San1 must function with an alternate E2 such as 
Cdc34 if Ubc1 was unavailable. Future work is required to uncover exactly how Ubc1 and 
Cdc34 coordinate their activities with San1 in the cell. Importantly, the reconstituted in vitro 
ubiquitylation system developed here enables the direct comparison of Ubc1 and Cdc34 
activities, providing new insight into how PQC processes may function in the cell. 
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Figure 9. Single-turnover reactions demonstrate that SCF-bound substrate is far more rapidly converted into 
ubiquitylated product than San1-bound substrate. (A) Single-turnover ubiquitylation reactions were carried out in 
the presence of either WT Ubc1 and KR San1 (1 µM, lanes 2-4; 2.5 µM, lanes 5-7) or WT Cdc34 and KR San1 
(lanes 8-10). Notice that San1 peptide ubiquitylation is similar in reactions containing either 1 µM or 2.5 µM KR 
San1, suggesting that 1 µM San1 is sufficient to saturate San1 peptide. PO (peptide only) indicates a reaction 
containing San1 peptide where all additional reaction components were excluded. (B) Quantification of the 
conversion of San1 peptide substrate into products containing one or more ubiquitins. Error bars represent the 
standard errors of measurement derived from duplicate data points. (C) Single-turnover ubiquitylation reactions 
were carried out in the presence of WT UbcH5c and WT human Cdc34 (hCdc34) and neddylated SCF. Notice that 
nearly all β-catenin peptide substrate (β-cat) is converted into ubiquitylated product by 10 seconds. (D) 
Quantification of the conversion of β-catenin substrate into products containing one or more ubiquitins. Error bars 
represent the standard errors of measurement derived from duplicate data points. 
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Experimental Procedures 
Cloning 
All San1 constructs were amplified by PCR from previously published templates 
(Fredrickson, Clowes Candadai, et al., 2013). The 5’ primer contained coding sequences for a 
TEV protease cleavage site followed by a Protein Kinase A (PKA) phosphorylation consensus 
motif (5’-GGCGGATCCGAGAACCTGTACTTCC-
AGGGCCGTCGCGGTAGCCTGAGTGAAAGTGGTCAAGAACAAAACA-3’) and the 3’ 
primer contained a coding sequence for an eight histidine tag that was appended to the San1 C-
terminus (5’-GGCCTCGAGTTAATGGTGATGGTGAT-
GGTGATGGTGTTGTGATGATCGTTGCTCATTG-3’). PCR products were digested with the 
BamHI and Xho1 restriction enzymes followed by ligation into the pGex-4T expression vector. 
All constructs were verified through DNA sequencing. 
Protein Expression and Purification 
All recombinant proteins were expressed in Escherichia coli using Rosetta 2(DE3)pLysS 
competent cells (Novagen). Yeast WT and Δ190 Cdc34 were expressed and purified as 
previously described (Kleiger, Hao, et al., 2009; Pierce et al., 2009). Yeast Ubc1 was expressed 
and purified essentially as previously described (Rodrigo-Brenni & Morgan, 2007) with the 
following modifications. Bacterial cells were grown at 37°C to an optical density of 0.8, after 
which expression was induced with IPTG for 3 hours followed by centrifugation and storage of 
the cell pellets at -80°C. Frozen cell pellets were solubilized in a buffer containing 30 mM Tris, 
pH 7.5, 250 mM NaCl, 20 mM imidazole, 0.1% IgePal, 5% glycerol, and protease inhibitor 
cocktail (PIC, Pierce) followed by sonication. The lysate was cleared by centrifugation and 
25 
 
incubated with Nickel-NTA Agarose beads (Qiagen) and gentle agitation for 1 hour at 4°C.  The 
beads were then repeatedly washed with lysis buffer prior to the addition of elution buffer (50 
mM HEPES pH 7.5, 200 mM NaCl, and 300 mM imidazole). The eluted protein was 
concentrated (Amicon Ultra-4, 10,000 NMWL) and loaded onto a Superdex 75 gel filtration 
column (GE Healthcare) that had been equilibrated in storage buffer (30 mM Tris, pH 8.0, 100 
mM NaCl, 1 mM DTT, and 10% glycerol). Fractions containing Ubc1 were collected and 
concentrated to 170 µM (Fig. 1) prior to snap freezing in liquid nitrogen and storage at -80°C. 
  E. coli cells for San1 expression were initially grown at 37° C in LB supplemented with 
ampicillin (100 ug/mL) and chloramphenicol (25 ug/mL). When the cultures reached an optical 
density of 0.8, the bacterial cells were then transferred to fresh media lacking antibiotics. Protein 
expression was induced overnight at 16° C using IPTG (0.4 mM). Bacterial cell pellets were 
solubilized in lysis buffer (30 mM Tris, pH 7.5, 200 mM NaCl, 5 mM DTT, 1 mM EDTA, 10% 
glycerol, and PIC) and disrupted by sonication. Lysates were prepared by centrifugation and then 
incubated with Glutathione Sepharose 4B beads (GE Healthcare Life Sciences) for 3 hours at 4° 
C. Beads were then collected and washed repeatedly with lysis buffer lacking PIC and EDTA. 
Recombinant GST-San1 protein was eluted in a buffer containing 50 mM tris, pH 8.0, 200 mM 
NaCl, and 40 mM glutathione. These proteins were then incubated with TEV protease overnight 
at 4°C, followed by loading onto a 1 mL HisTrap HP column (GE Healthcare Life Sciences) that 
had been equilibrated in buffer A (50 mM HEPES, pH 7.5, 200 mM NaCl, 20 mM imidazole, 
5% glycerol). Histidine tagged San1 proteins were eluted from the column using a linear gradient 
of buffer B (50 mM HEPES, pH 7.5, 200 mM NaCl, 300 mM imidazole, and 5% glycerol). 
Fractions containing San1 were dialyzed into storage buffer by repeatedly diluting the protein 
sample in storage buffer followed by concentration (Amicon Ultra-4 10,000 NMWL). Purified 
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San1 proteins (Fig. 1) were concentrated to approximately 20 µM and flash frozen in liquid 
nitrogen prior to storage at -80°C. 
In vitro San1 Auto-Ubiquitylation Assay 
San1 auto-ubiquitylation assays were performed in a reaction buffer containing 30 mM 
Tris, pH 7.5, 5 mM MgCl2, 2 mM ATP, and 2 mM DTT. San1 proteins (8 µM) were 
radiolabeled in the presence of γ-32P labeled ATP (Perkin Elmer) and cAMP-dependent Protein 
Kinase (New England Biolabs) for 1 hour at 30° C.  WT ubiquitin (60 µM), human E1 (1 µM; 
note that San1 activity was indistinguishable in the presence of either human or yeast E1), and 
either Cdc34 or Ubc1 (10 µM) were first incubated for 1 minute at room temperature, followed 
by the addition of San1 (1 µM). Time-points were quenched in SDS-PAGE loading buffer, and 
San1 substrate and ubiquitylated products were resolved on 7.5% SDS-PAGE gels (Lonza). Gels 
were then dried and exposed to a phosphor screen prior to imaging on a Typhoon 9410. The 
quantification of substrate and product levels was performed using ImageQuant software (GE 
Healthcare). The fraction of ubiquitin-modified San1 was calculated as the ratio of San1 products 
that had been modified by 1 or more ubiquitins and the total signal in the lane. Background 
corrections were performed using a ubiquitylation reaction that contained all components except 
ubiquitin. The rate of product formation in Fig. 2 was determined by performing linear 
regression (GraphPad Prism, Version 6.07). The initial rate of product formation in Fig. 3 was 
determined by fitting the data to a one-phase association model by nonlinear regression. The 
initial velocity was then estimated by determining the slope of the linear phase of the curve. 
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E2 Activation Assay 
The stimulation of E2 activity by San1 was followed using a previously described di-
ubiquitin synthesis assay (Kleiger, Hao, et al., 2009). E2 activation assays were performed in the 
same reaction buffer as above. Human E1 (1 µM), 32P-labeled K48R donor ubiquitin (10 µM), 
and either Cdc34 or Ubc1 (10 µM) were briefly incubated, followed by either the addition of 
San1 protein where all lysine residues had been mutated to arginine (KR San1; 1 µM) or buffer 
and incubation for 2 minutes. Acceptor ubiquitin that contained an aspartic acid residue at its C-
terminus (50 µM) was then introduced to initiate di-ubiquitin synthesis. Time points were 
quenched in non-reducing SDS-PAGE loading buffer. Reaction substrates and products were 
resolved on 4-20% SDS-PAGE gels (Lonza). The amounts of substrates and products were 
quantified using ImageQuant (GE Healthcare). The amount of di-ubiquitin (pmol) was plotted as 
a function of time and the rates of product formation were determined by linear regression. 
San1 Peptide Multi-Turnover Ubiquitylation Reactions 
The San1 peptide (Acetyl-CGSRRGSYNASSGEQMLSRTGFFLVLIVGQL-HNPVK; 
New England Peptide) was radiolabeled (50 µM) in the presence of γ-32P labeled ATP (Perkin 
Elmer) and cAMP-dependent Protein Kinase (New England Biolabs) for 1 hour at 30° C in a 
reaction buffer that had been supplemented with tween-20 (0.1%). All multi-turnover reactions 
were carried out in a reaction buffer containing 30 mM Tris, pH 7.5, 5 mm MgCl2, 2 mM ATP, 
2 mM DTT, and 0.1% Tween-20. Human E1 (1 µM), WT or Lys 48 only ubiquitin (60 µM; 
Boston Biochem), E2 (10 µM), and KR San1 (0.5 µM) were incubated for 2 minutes. San1 
Peptide (5 µM) was then added to initiate the reaction. Time-points were quenched in SDS-
PAGE buffer and ubiquitylated products were separated on 4-20% SDS-PAGE gels (Lonza). 
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Gels were processed and the fraction of ubiquitylated San1 peptide was calculated by dividing 
the amount of peptide that had been modified by 1 or more ubiquitins by the total signal in the 
lane. 
Determining the Km of Cdc34 or Ubc1 for San1 
Experiments to estimate the Km of Cdc34 or Ubc1 for San1 were performed in a reaction 
buffer containing 30 mM Tris, pH 7.5, 5 mm MgCl2, 2 mM ATP, 2 mM DTT, and 0.1% Tween-
20. A master mix containing ubiquitin (60 µM) and human E1 (1 µM) in reaction buffer was 
assembled and distributed to individual tubes. Next, a 2-fold dilution series was established for 
either yCdc34 (WT and Δ190) or Ubc1. Aliquots of either Cdc34 or Ubc1 at each concentration 
were then added to each tube containing E1 and ubiquitin and incubated for 1 minute. KR San1 
(0.1 µM) was then added to each tube and incubated for an additional 2 minutes. Radiolabeled 
San1 peptide (5 µM) was added to initiate the reaction. Reactions were quenched with 2X SDS-
PAGE loading buffer at 6 minutes (Ubc1) or 10 minutes (yCdc34) in order to maintain 
approximately 20-30 percent product conversion and ensure linearity of the reaction velocities at 
the highest concentrations of Ubc1 or yCdc34. Substrates and products were resolved on a 4-
20% SDS-PAGE gel, dried, and exposed to a phosphor screen. Quantification of substrate and 
product was performed as described above. The rate of San1 peptide ubiquitylation was 
calculated by dividing the fraction of ubiquitylated product by the time of incubation and 
multiplying by the ratio of the concentrations of peptide and KR San1. These data were then fit 
to the Michaelis-Menten equation by nonlinear regression. 
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Single-Turnover Reaction 
San1 single-turnover reactions were carried out in a reaction buffer containing 30 mM 
Tris, pH 7.5, 5 mm MgCl2, 2 mM ATP, 2 mM DTT, and 0.1% Tween-20. Human E1 (1 µM), 
wild type ubiquitin (60 µM), E2 (10 µM), and KR San1 (2.5 µM or 1 µM) were mixed together 
and incubated for 2 minutes. Radiolabeled San1 peptide (0.5 µM) was added to initiate the 
reaction. Reactions were quenched in SDS-PAGE buffer at indicated time points and products 
were separated on 4-20% SDS-PAGE gel. Gels were dried, exposed, imaged and quantified as 
described for the multi-turnover reactions.  
 Previously described SCF single-turnover reactions (Saha & Deshaies, 2008) were 
carried out in reaction buffer containing 30 mM Tris (pH 7.5), 100 mM NaCl, 5 mM MgCl2, 2 
mM ATP, and 2 mM DTT. Human E1 (1 µM), wild type ubiquitin (60 µM), and both UbcH5c 
and human Cdc34 (10 µM each) were mixed together and incubated for 1 minute. Equimolar 
concentrations of neddylated Cul1–Rbx1 and βTrcp–Skp1 complexes (Saha & Deshaies, 2008) 
(1 µM) were added and incubated for 1 minute. Radiolabeled β-catenin peptide substrate (0.25 
µM) was added to initiate the reaction. Reactions were quenched in 2X SDS-PAGE loading 
buffer at the indicated time points and substrates and products were separated on a 18% SDS-
PAGE gel. Gels were dried, exposed, imaged and quantified as described as above. 
 
 
 
 
 
30 
 
References 
Aguzzi, A., & O'Connor, T. (2010). Protein aggregation diseases: pathogenicity and therapeutic 
perspectives. Nat Rev Drug Discov, 9(3), 237-248. doi:10.1038/nrd3050 
 
Amm, I., Sommer, T., & Wolf, D. H. (2014). Protein quality control and elimination of protein 
waste: the role of the ubiquitin-proteasome system. Biochim Biophys Acta, 1843(1), 182-
196. doi:10.1016/j.bbamcr.2013.06.031 
 
Baker, M. J., Tatsuta, T., & Langer, T. (2011). Quality control of mitochondrial proteostasis. 
Cold Spring Harb Perspect Biol, 3(7). doi:10.1101/cshperspect.a007559 
 
Bengtson, M. H., & Joazeiro, C. A. (2010). Role of a ribosome-associated E3 ubiquitin ligase in 
protein quality control. Nature, 467(7314), 470-473. doi:10.1038/nature09371 
 
Brandman, O., & Hegde, R. S. (2016). Ribosome-associated protein quality control. Nat Struct 
Mol Biol, 23(1), 7-15. doi:10.1038/nsmb.3147 
 
Branigan, E., Plechanovova, A., Jaffray, E. G., Naismith, J. H., & Hay, R. T. (2015). Structural 
basis for the RING-catalyzed synthesis of K63-linked ubiquitin chains. Nat Struct Mol 
Biol, 22(8), 597-602. doi:10.1038/nsmb.3052 
 
Buchberger, A., Bukau, B., & Sommer, T. (2010). Protein quality control in the cytosol and the 
endoplasmic reticulum: brothers in arms. Mol Cell, 40(2), 238-252. 
31 
 
doi:10.1016/j.molcel.2010.10.001 
 
Chen, B., Retzlaff, M., Roos, T., & Frydman, J. (2011). Cellular strategies of protein quality 
control. Cold Spring Harb Perspect Biol, 3(8), a004374. 
doi:10.1101/cshperspect.a004374 
 
Christensen, D. E., Brzovic, P. S., & Klevit, R. E. (2007). E2-BRCA1 RING interactions dictate 
synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol, 14(10), 
941-948. doi:10.1038/nsmb1295 
 
Christianson, J. C., & Ye, Y. (2014). Cleaning up in the endoplasmic reticulum: ubiquitin in 
charge. Nat Struct Mol Biol, 21(4), 325-335. doi:10.1038/nsmb.2793 
 
Das, R., Liang, Y. H., Mariano, J., Li, J., Huang, T., King, A., . . . Byrd, R. A. (2013). Allosteric 
regulation of E2:E3 interactions promote a processive ubiquitination machine. EMBO J, 
32(18), 2504-2516. doi:10.1038/emboj.2013.174 
 
Dasgupta, A., Ramsey, K. L., Smith, J. S., & Auble, D. T. (2004). Sir Antagonist 1 (San1) is a 
ubiquitin ligase. J Biol Chem, 279(26), 26830-26838. doi:10.1074/jbc.M400894200 
 
Deshaies, R. J., & Joazeiro, C. A. (2009). RING domain E3 ubiquitin ligases. Annu Rev 
Biochem, 78, 399-434. doi:10.1146/annurev.biochem.78.101807.093809 
 
32 
 
Dou, H., Buetow, L., Sibbet, G. J., Cameron, K., & Huang, D. T. (2012). BIRC7-E2 ubiquitin 
conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat 
Struct Mol Biol, 19(9), 876-883. doi:10.1038/nsmb.2379 
 
Eisele, F., & Wolf, D. H. (2008). Degradation of misfolded protein in the cytoplasm is mediated 
by the ubiquitin ligase Ubr1. FEBS Lett, 582(30), 4143-4146. 
doi:10.1016/j.febslet.2008.11.015 
 
Fang, N. N., Chan, G. T., Zhu, M., Comyn, S. A., Persaud, A., Deshaies, R. J., . . . Mayor, T. 
(2014). Rsp5/Nedd4 is the main ubiquitin ligase that targets cytosolic misfolded proteins 
following heat stress. Nat Cell Biol, 16(12), 1227-1237. doi:10.1038/ncb3054 
 
Fang, N. N., Ng, A. H., Measday, V., & Mayor, T. (2011). Hul5 HECT ubiquitin ligase plays a 
major role in the ubiquitylation and turnover of cytosolic misfolded proteins. Nat Cell 
Biol, 13(11), 1344-1352. doi:10.1038/ncb2343 
 
Fredrickson, E. K., Clowes Candadai, S. V., Tam, C. H., & Gardner, R. G. (2013). Means of 
self-preservation: how an intrinsically disordered ubiquitin-protein ligase averts self-
destruction. Mol Biol Cell, 24(7), 1041-1052. doi:10.1091/mbc.E12-11-0811 
 
Fredrickson, E. K., Gallagher, P. S., Clowes Candadai, S. V., & Gardner, R. G. (2013). Substrate 
recognition in nuclear protein quality control degradation is governed by exposed 
hydrophobicity that correlates with aggregation and insolubility. J Biol Chem, 288(9), 
33 
 
6130-6139. doi:10.1074/jbc.M112.406710 
 
Fredrickson, E. K., Rosenbaum, J. C., Locke, M. N., Milac, T. I., & Gardner, R. G. (2011). 
Exposed hydrophobicity is a key determinant of nuclear quality control degradation. Mol 
Biol Cell, 22(13), 2384-2395. doi:10.1091/mbc.E11-03-0256 
 
Gallagher, P. S., Clowes Candadai, S. V., & Gardner, R. G. (2014). The requirement for 
Cdc48/p97 in nuclear protein quality control degradation depends on the substrate and 
correlates with substrate insolubility. J Cell Sci, 127(Pt 9), 1980-1991. 
doi:10.1242/jcs.141838 
 
Gardner, R. G., Nelson, Z. W., & Gottschling, D. E. (2005). Degradation-mediated protein 
quality control in the nucleus. Cell, 120(6), 803-815. doi:10.1016/j.cell.2005.01.016 
 
Heck, J. W., Cheung, S. K., & Hampton, R. Y. (2010). Cytoplasmic protein quality control 
degradation mediated by parallel actions of the E3 ubiquitin ligases Ubr1 and San1. Proc 
Natl Acad Sci U S A, 107(3), 1106-1111. doi:10.1073/pnas.0910591107 
 
Heo, J. M., Ordureau, A., Paulo, J. A., Rinehart, J., & Harper, J. W. (2015). The PINK1-
PARKIN Mitochondrial Ubiquitylation Pathway Drives a Program of OPTN/NDP52 
Recruitment and TBK1 Activation to Promote Mitophagy. Mol Cell, 60(1), 7-20. 
doi:10.1016/j.molcel.2015.08.016 
 
34 
 
Hipp, M. S., Park, S. H., & Hartl, F. U. (2014). Proteostasis impairment in protein-misfolding 
and -aggregation diseases. Trends Cell Biol, 24(9), 506-514. 
doi:10.1016/j.tcb.2014.05.003 
 
Kim, J. H., Choi, J. S., Kim, S., Kim, K., Myung, P. K., Park, S. G., . . . Park, B. C. (2015). 
Synergistic effect of two E2 ubiquitin conjugating enzymes in SCF(hFBH1) catalyzed 
polyubiquitination. BMB Rep, 48(1), 25-29.  
 
Kim, Y. E., Hipp, M. S., Bracher, A., Hayer-Hartl, M., & Hartl, F. U. (2013). Molecular 
chaperone functions in protein folding and proteostasis. Annu Rev Biochem, 82, 323-355. 
doi:10.1146/annurev-biochem-060208-092442 
 
Kleiger, G., Hao, B., Mohl, D. A., & Deshaies, R. J. (2009). The acidic tail of the Cdc34 
ubiquitin-conjugating enzyme functions in both binding to and catalysis with ubiquitin 
ligase SCFCdc4. J Biol Chem, 284(52), 36012-36023. doi:M109.058529 [pii] 
10.1074/jbc.M109.058529 
 
Kleiger, G., & Mayor, T. (2014). Perilous journey: a tour of the ubiquitin-proteasome system. 
Trends Cell Biol, 24(6), 352-359. doi:10.1016/j.tcb.2013.12.003 
 
Kleiger, G., Saha, A., Lewis, S., Kuhlman, B., & Deshaies, R. J. (2009). Rapid E2-E3 assembly 
and disassembly enable processive ubiquitylation of cullin-RING ubiquitin ligase 
substrates. Cell, 139(5), 957-968. doi:S0092-8674(09)01356-7 [pii] 
35 
 
10.1016/j.cell.2009.10.030 
 
Komander, D., & Rape, M. (2012). The ubiquitin code. Annu Rev Biochem, 81, 203-229. 
doi:10.1146/annurev-biochem-060310-170328 
 
Lee, J. Y., Nagano, Y., Taylor, J. P., Lim, K. L., & Yao, T. P. (2010). Disease-causing mutations 
in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent 
mitophagy. J Cell Biol, 189(4), 671-679. doi:10.1083/jcb.201001039 
 
Lu, Y., Lee, B. H., King, R. W., Finley, D., & Kirschner, M. W. (2015). Substrate degradation 
by the proteasome: a single-molecule kinetic analysis. Science, 348(6231), 1250834. 
doi:10.1126/science.1250834 
 
Murata, S., Minami, Y., Minami, M., Chiba, T., & Tanaka, K. (2001). CHIP is a chaperone-
dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep, 2(12), 1133-1138. 
doi:10.1093/embo-reports/kve246 
 
Petroski, M. D., & Deshaies, R. J. (2005). Mechanism of lysine 48-linked ubiquitin-chain 
synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34. Cell, 123(6), 1107-
1120.  
 
Pierce, N. W., Kleiger, G., Shan, S. O., & Deshaies, R. J. (2009). Detection of sequential 
polyubiquitylation on a millisecond timescale. Nature, 462(7273), 615-619. 
36 
 
doi:nature08595 [pii] 
10.1038/nature08595 
 
Piotrowski, J., Beal, R., Hoffman, L., Wilkinson, K. D., Cohen, R. E., & Pickart, C. M. (1997). 
Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined 
lengths. J Biol Chem, 272(38), 23712-23721.  
 
Plechanovova, A., Jaffray, E. G., Tatham, M. H., Naismith, J. H., & Hay, R. T. (2012). Structure 
of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature, 489(7414), 
115-120. doi:10.1038/nature11376 
 
Pruneda, J. N., Littlefield, P. J., Soss, S. E., Nordquist, K. A., Chazin, W. J., Brzovic, P. S., & 
Klevit, R. E. (2012). Structure of an E3:E2~Ub complex reveals an allosteric mechanism 
shared among RING/U-box ligases. Mol Cell, 47(6), 933-942. 
doi:10.1016/j.molcel.2012.07.001 
 
Rodrigo-Brenni, M. C., & Morgan, D. O. (2007). Sequential E2s drive polyubiquitin chain 
assembly on APC targets. Cell, 130(1), 127-139. doi:S0092-8674(07)00665-4 [pii] 
10.1016/j.cell.2007.05.027 
 
Rosenbaum, J. C., Fredrickson, E. K., Oeser, M. L., Garrett-Engele, C. M., Locke, M. N., 
Richardson, L. A., . . . Gardner, R. G. (2011). Disorder targets misorder in nuclear quality 
control degradation: a disordered ubiquitin ligase directly recognizes its misfolded 
37 
 
substrates. Mol Cell, 41(1), 93-106. doi:10.1016/j.molcel.2010.12.004 
 
Rosenbaum, J. C., & Gardner, R. G. (2011). How a disordered ubiquitin ligase maintains order in 
nuclear protein homeostasis. Nucleus, 2(4), 264-270. doi:10.4161/nucl.2.4.16118 
 
Saha, A., & Deshaies, R. J. (2008). Multimodal activation of the ubiquitin ligase SCF by Nedd8 
conjugation. Mol Cell, 32(1), 21-31.  
 
Sarraf, S. A., Raman, M., Guarani-Pereira, V., Sowa, M. E., Huttlin, E. L., Gygi, S. P., & Harper, 
J. W. (2013). Landscape of the PARKIN-dependent ubiquitylome in response to 
mitochondrial depolarization. Nature, 496(7445), 372-376. doi:10.1038/nature12043 
 
Schulman, B. A., & Harper, J. W. (2009). Ubiquitin-like protein activation by E1 enzymes: the 
apex for downstream signalling pathways. Nat Rev Mol Cell Biol, 10(5), 319-331. 
doi:10.1038/nrm2673 
 
Scott, D. C., Sviderskiy, V. O., Monda, J. K., Lydeard, J. R., Cho, S. E., Harper, J. W., & 
Schulman, B. A. (2014). Structure of a RING E3 trapped in action reveals ligation 
mechanism for the ubiquitin-like protein NEDD8. Cell, 157(7), 1671-1684. 
doi:10.1016/j.cell.2014.04.037 
 
Shabek, N., Herman-Bachinsky, Y., Buchsbaum, S., Lewinson, O., Haj-Yahya, M., Hejjaoui, M., 
. . . Ciechanover, A. (2012). The size of the proteasomal substrate determines whether its 
38 
 
degradation will be mediated by mono- or polyubiquitylation. Mol Cell, 48(1), 87-97. 
doi:10.1016/j.molcel.2012.07.011 
 
Thrower, J. S., Hoffman, L., Rechsteiner, M., & Pickart, C. M. (2000). Recognition of the 
polyubiquitin proteolytic signal. EMBO J, 19(1), 94-102.  
 
Tramutola, A., Di Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. (2016). It Is All 
about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in 
Alzheimer Disease. Oxid Med Cell Longev, 2016, 2756068. doi:10.1155/2016/2756068 
 
Verma, R., Oania, R. S., Kolawa, N. J., & Deshaies, R. J. (2013). Cdc48/p97 promotes 
degradation of aberrant nascent polypeptides bound to the ribosome. Elife (Cambridge), 
2, e00308. doi:10.7554/eLife.00308 
 
Wang, F., Durfee, L. A., & Huibregtse, J. M. (2013). A cotranslational ubiquitination pathway 
for quality control of misfolded proteins. Mol Cell, 50(3), 368-378. 
doi:10.1016/j.molcel.2013.03.009 
 
Wickliffe, K. E., Lorenz, S., Wemmer, D. E., Kuriyan, J., & Rape, M. (2011). The mechanism of 
linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell, 144(5), 769-781. 
doi:S0092-8674(11)00111-5 [pii] 
10.1016/j.cell.2011.01.035 
 
39 
 
Wickliffe, K. E., Williamson, A., Meyer, H. J., Kelly, A., & Rape, M. (2011). K11-linked 
ubiquitin chains as novel regulators of cell division. Trends Cell Biol, 21(11), 656-663. 
doi:S0962-8924(11)00174-7 [pii] 
10.1016/j.tcb.2011.08.008 
 
Williamson, A., Wickliffe, K. E., Mellone, B. G., Song, L., Karpen, G. H., & Rape, M. (2009). 
Identification of a physiological E2 module for the human anaphase-promoting complex. 
Proc Natl Acad Sci U S A, 106(43), 18213-18218. doi:10.1073/pnas.0907887106 
 
Woulfe, J. (2008). Nuclear bodies in neurodegenerative disease. Biochim Biophys Acta, 
1783(11), 2195-2206. doi:10.1016/j.bbamcr.2008.05.005 
 
Wu, K., Kovacev, J., & Pan, Z. Q. (2010). Priming and extending: a UbcH5/Cdc34 E2 handoff 
mechanism for polyubiquitination on a SCF substrate. Mol Cell, 37(6), 784-796. 
doi:S1097-2765(10)00208-X [pii] 
10.1016/j.molcel.2010.02.025 
 
Ye, Y., & Rape, M. (2009). Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell 
Biol, 10(11), 755-764. doi:10.1038/nrm2780 
 
 
 
 
 
40 
 
Curriculum Vitae 
Rebeca L. Ibarra 
4505 S. Maryland Parkway 
Las Vegas, NV 89154-4003 
Department of Chemistry and Biochemistry 
University of Nevada, Las Vegas 
Telephone: (702) 523-6837 
Email: ibarra10@unlv.nevada.edu 
 
Education 
University of Nevada, Las Vegas 
B.S., Biological Sciences, 2014 
M.S., Biochemistry, 2016 
 
Thesis Title 
 
The San1 Ubiquitin Ligase Functions Preferentially with Ubiquitin-Conjugating Enzyme Ubc1 
During Protein Quality Control 
 
Thesis Examination Committee:  
 
Chairperson, Gary Kleiger, Ph.D. 
Committee Member, Ernesto Abel-Santos, Ph.D. 
Committee Member, Hong Sun, M.D., Ph.D. 
Graduate Faculty Representative, Nora Caberoy, Ph.D. 
 
 
 
